Skill UI

Programmatic access to the COSMIC cancer mutation database for downloading mutations, Cancer Gene Census, mutational signatures, fusions, copy number, expression, and resistance data to fuel oncology research or bioinformatics pipelines after authentication.

This tool provides access to the Cancer Dependency Map (DepMap) data, derived from genome-wide CRISPR screens, RNAi, and compound sensitivity assays. It allows users to query gene dependency scores, identify cancer-specific vulnerabilities, predict synthetic lethal interactions, and validate potential oncology drug targets across various cancer cell lines.

A comprehensive guide for authors assessing the suitability of their clinical or translational oncology studies for Annals of Oncology (ESMO). It covers the journal's high standards for rigorous, practice-changing research, including requirements for robust trial design, biomarker validation, adherence to specific reporting guidelines (CONSORT, STROBE), and alignment with ESMO best practices. This is a venue-fit aid, not medical or regulatory advice.

This skill helps authors determine if their oncology manuscript is suitable for a major clinical journal, such as CA: A Cancer Journal for Clinicians. It provides a detailed guide covering the journal's editorial DNA, required scope (e.g., epidemiology, synthesis), evidence bar, and house style. Use this to re-frame and optimize your manuscript before submission, ensuring it meets the high standards of authoritative medical publishing.

This skill provides a comprehensive guide for authors targeting Cancer Discovery (AACR) or similar high-impact oncology venues. It details the journal's specific fit, required evidence standards, structural expectations, and potential desk-reject risks for manuscripts in cancer biology and translational oncology. Usage is recommended when selecting a venue, framing a manuscript, or preparing for submission.

A comprehensive guide designed to assess whether a molecular or translational oncology study meets the high standards of a top-tier journal like Cancer Cell. It helps researchers critically evaluate their work's mechanistic depth and translational relevance, providing actionable steps before investing in full manuscript submission.

This skill provides a comprehensive guide for authors submitting clinical, translational, or epidemiological oncology studies to JAMA Oncology. It covers venue fit assessment, required methodological rigor (e.g., RCTs, RWE, biomarker validation), mandatory reporting guidelines (CONSORT, STROBE, PRISMA), and adherence to the journal's specific house style and submission checklist. It is a crucial pre-submission aid, ensuring the research addresses a clinically meaningful, decision-relevant question.

A comprehensive skill designed for authors targeting the Journal of Clinical Oncology (JCO). It provides an exhaustive checklist covering the journal's high academic standards, required evidence depth (such as Phase III randomized controlled trials), appropriate study scope (solid tumors, biomarkers), mandatory formatting, and the latest submission guidelines. Use this tool to optimize your manuscript and improve its suitability for publication in a top-tier oncology journal.

This comprehensive guide assists authors in determining if their authoritative clinical-oncology review or perspective fits the scope of Nature Reviews Clinical Oncology. It details the required synthesis depth, scope, commissioned submission process, and warns against submitting primary research, ensuring authors adhere to the specialized guidelines for this prestigious journal.

This comprehensive skill acts as a venue-selection and re-framing tool for authors targeting The Lancet Oncology. It provides deep insight into the journal's specific requirements, including methodological rigor (CONSORT, PRISMA), required evidence strength (Phase III RCTs, definitive biomarkers), structural elements (structured abstract, 'Added value' panel), and current submission best practices. Use this guide to assess if your clinical oncology manuscript is sufficiently advanced and impactful for this prestigious global journal.